Market Closed - 02:25:07 17/11/2026 am IST 5-day change 1st Jan Change
0.003000 EUR 0.00% Intraday chart for MagForce AG 0.00% +50.00%
Current year+50.00%
3 months-14.29%
Current year+50.00%
1 week 0
Extreme 0.003
0
1 month 0
Extreme 0.003
0
Current year 0
Extreme 0.001
0.02
1 year 0
Extreme 0.001
0.02
3 years 0
Extreme 0.0002
0.02
5 years 0
Extreme 0.0002
0.02
10 years 0
Extreme 0.0002
0.02
Manager TitleAgeSince
Chief Executive Officer 86 01/09/2013
Director of Finance/CFO 55 01/10/2012
Director TitleAgeSince
Chairman 54 12/08/2021
Director/Board Member 45 -
Director/Board Member 54 -
Date Insider Type Main position Quantity % Market Cap. Importance
16/12/20 Buy

Chief Executive Officer

2,50,000 0.9045%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+20.00%+87.50% 1L
-1.29%-1.76%+51.98%+64.66% 6.63TCr
-0.09%+2.79%+10.75%+95.02% 6.06TCr
+0.63%+1.64%+24.25%+89.70% 5.55TCr
-1.26%-1.45%+9.20%+117.42% 4.76TCr
-0.15%-5.06%+22.49%+29.27% 4.37TCr
-3.15%-16.63%+141.35%+685.27% 3.73TCr
+0.23%+1.66%+14.85%+49.06% 3.66TCr
+2.35%-3.61%+78.64%+60.70% 3.22TCr
+1.42%+5.84%-37.75%+402.78% 2.66TCr
Average -0.11%+0.29%+33.58%+168.14% 4TCr
Weighted average by Cap. -0.27%+0.33%+34.96%+152.30%

Financials

2020 2021
Net sales 15.02L 16.54L 13.88L 12.54L 23.66L 16Cr 24.49L 1.67Cr 66.14L 8.33Cr 62.05L 60.74L 26Cr 10.77L 11.86L 10L 9L 16.96L 11Cr 17.56L 1.2Cr 47.42L 5.97Cr 44.49L 43.55L 19Cr
Net income 1.47Cr 1.62Cr 1.36Cr 1.23Cr 2.32Cr 152.41Cr 2.4Cr 16Cr 6.49Cr 82Cr 6.09Cr 5.96Cr 259.07Cr -1.06Cr -1.16Cr -97.7L -88.25L -1.67Cr -109.29Cr -1.72Cr -12Cr -4.66Cr -59Cr -4.37Cr -4.28Cr -185.77Cr
Net Debt - -
Logo MagForce AG
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.
Employees
33
Date Price Change Volume
17/26/17 €0.003000 0.00% 725
13/26/13 €0.003000 0.00% 32,770
12/26/12 €0.003000 0.00% 0
11/26/11 €0.003000 0.00% 350
10/26/10 €0.003000 0.00% 375